BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 36324143)

  • 1. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study.
    Hadaegh F; Abdi A; Kohansal K; Hadaegh P; Azizi F; Tohidi M
    Front Endocrinol (Lausanne); 2023; 14():1164771. PubMed ID: 37305040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
    McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
    J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in change of metabolic syndrome status and its components on all-cause and cause-specific mortalities: Over a decade follow-up study.
    Afaghi S; Esmaeili F; Azizi F; Hadaegh F
    Nutr Metab Cardiovasc Dis; 2023 Nov; 33(11):2128-2140. PubMed ID: 37580229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

  • 7. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study.
    Moazzeni SS; Hizomi Arani R; Deravi N; Hasheminia M; Khalili D; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2021 Jul; 20(1):141. PubMed ID: 34253199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study.
    Masrouri S; Moazzeni SS; Cheraghloo N; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):269. PubMed ID: 36463175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality.
    Honarvar M; Mehran L; Masoumi S; Agahi S; Khalili S; Azizi F; Amouzegar A
    Sci Rep; 2023 Sep; 13(1):14621. PubMed ID: 37669997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex- specific clustering of metabolic syndrome components and incidence of cardiovascular disease: A latent class analysis in a population-based cohort study.
    Ahanchi NS; Hadaegh F; Azizi F; Khalili D
    J Diabetes Complications; 2021 Jul; 35(7):107942. PubMed ID: 33965337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary calcium density in relation to coronary heart disease and cardiovascular disease in adults with diabetes or metabolic syndrome: the Multi-ethnic Study of Atherosclerosis (MESA).
    Zhao Y; Malik S; Criqui MH; Allison MA; Budoff MJ; Sandfort V; Wong ND
    BMC Cardiovasc Disord; 2022 Dec; 22(1):536. PubMed ID: 36494811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
    Arafa A; Kashima R; Matsumoto C; Kokubo Y
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study.
    Rachas A; Raffaitin C; Barberger-Gateau P; Helmer C; Ritchie K; Tzourio C; Amouyel P; Ducimetière P; Empana JP
    Heart; 2012 Apr; 98(8):650-5. PubMed ID: 22505463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults.
    Masrouri S; Shapiro MD; Khalili D; Hadaegh F
    Eur J Prev Cardiol; 2024 Apr; 31(6):744-753. PubMed ID: 38323650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in risk factors for coronary heart disease events: a prospective cohort study in Iran.
    Ramezankhani A; Azizi F; Hadaegh F
    Sci Rep; 2023 Dec; 13(1):22398. PubMed ID: 38104178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.